fda statement bpc-157 not approved fda.gov
fda statement bpc-157 not approved fda.gov An advisory panel narrowly voted to ease restrictions on injectable “wellness” peptides like and TB-500, despite FDA scientists warning there's little evidence they're safe or effective. If the FDA follows add-on Color:Nardo Gray Product
Baker’s notes & crumb story
Description
fda statement bpc-157 not approved fda.gov An advisory panel narrowly voted to ease restrictions on injectable “wellness” peptides like and TB-500, despite FDA scientists warning there's little evidence they're safe or effective. If the FDA follows add-on Color:Nardo Gray Product
Product
Unless your compounding pharmacy provides specific documentation that their formulation tolerates room temperature for a defined period, assume compounded tirzepatide requires constant refrigeration
add-on
Color:Nardo Gray
That is a gaping hole that we have to fill at this point.” G